Scapin, Giovanna
Yang, Xiaoyu
Prosise, Winifred W
McCoy, Mark
Reichert, Paul
Johnston, Jennifer M
Kashi, Ramesh S
Strickland, Corey
Article History
Received: 19 July 2015
Accepted: 26 October 2015
First Online: 23 November 2015
Competing interests
: All authors are Merck & Co. Inc. employees, and pembrolizumab is a Merck marketed product called KEYTRUDA<sup>®</sup>.